Figure 3.
Kaplan-Meier estimates of OS after day 80 of aGVHD treatment initiation. The 2-year OS in the SS, SD, and SR groups were 68% (95% CI, 58-76), 68% (95% CI, 58-77), and 46% (95% CI, 35-55), respectively.
Kaplan-Meier estimates of OS after day 80 of aGVHD treatment initiation. The 2-year OS in the SS, SD, and SR groups were 68% (95% CI, 58-76), 68% (95% CI, 58-77), and 46% (95% CI, 35-55), respectively.